Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

DVAX Insider Trading

DYNAVAX TECHNOLOGIES CORP | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at DYNAVAX TECHNOLOGIES CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2021-08-28 03:07 2021-08-27 Hack Andrew A. F. Director SELL $16.22 2,000,000 $32,440,000 8,415,000 -19.2%
2021-08-26 02:35 2021-08-24 Novack David F Officer - President & COO OPT+S $14.00 10,000 $140,000 104,066 0.0%
2021-08-26 02:32 2021-08-24 Burgess Justin Officer - Principal Accounting Officer SELL $15.00 5,768 $86,520 3,721 -60.8%
2021-08-19 02:11 2021-08-16 Janssen Robert Officer - Senior Vice President OPT+S $12.36 2,917 $36,054 8,276 0.0%
2021-08-14 01:59 2021-08-11 Novack David F Officer - President & COO SELL $12.00 10,000 $120,000 107,399 -8.5%
2021-08-14 01:58 2021-08-11 Janssen Robert Officer - Senior Vice President OPT+S $12.06 49,583 $597,971 6,861 0.0%
2021-08-12 01:26 2021-08-09 Hack Andrew A. F. Director SELL $10.80 2,250,000 $24,300,000 8,524,000 -20.9%
2021-08-11 01:57 2021-08-06 Janssen Robert Officer - Senior Vice President SELL $10.75 80,000 $860,000 6,861 -92.1%
2021-04-03 01:00 2021-04-01 Novack David F Officer - President & COO SELL $9.92 20,000 $198,400 117,399 -14.6%
2021-03-27 01:46 2021-03-01 Burgess Justin Officer - Principal Accounting Officer OPT+S $8.86 4,144 $36,727 6,989 0.0%
2021-03-03 03:52 2021-03-01 Burgess Justin Officer - Principal Accounting Officer OPT+S $8.86 4,123 $36,542 7,010 0.0%
2021-02-04 02:28 2021-02-01 Janssen Robert Officer - Senior Vice President SELL $10.64 42,155 $448,529 86,485 -32.8%
2020-07-21 02:42 2020-07-17 Janssen Robert Officer - Senior Vice President SELL $11.09 50,000 $554,500 127,266 -28.2%
2020-05-29 00:13 2020-05-27 Hack Andrew A. F. Director BUY $5.00 1,000,000 $5,000,000 8,525,000 +13.3%
2020-05-20 02:05 2020-05-19 Janssen Robert Officer - Senior Vice President SELL $6.33 15,000 $94,950 177,266 -7.8%
2020-05-08 01:37 2020-05-05 Janssen Robert Officer - Senior Vice President SELL $4.50 37,000 $166,430 192,266 -16.1%
2019-08-13 02:27 2019-08-12 Phillips Peggy V Director BUY $3.00 16,666 $49,998 30,468 +120.8%
2019-08-13 02:24 2019-08-12 CANO FRANCIS Director BUY $3.00 16,667 $50,001 16,667 +100.0%
2019-08-13 02:23 2019-08-12 Novack David F Officer - Co-President and Senior VP BUY $3.00 16,667 $50,001 118,484 +16.4%
2019-06-05 02:07 2019-06-04 COFFMAN ROBERT Officer - Senior Vice President OPT+S $4.58 32,218 $147,687 77,768 0.0%
2019-06-05 02:01 2019-02-28 OSTRACH MICHAEL S Officer - Senior Vice President OPT+S $8.94 35,444 $316,763 81,800 0.0%
2019-03-02 04:01 2019-02-28 Johnson David Louis Officer - Vice President SELL $9.03 20,765 $187,508 32,021 -39.3%
2019-03-02 03:57 2019-02-28 COFFMAN ROBERT Officer - Senior Vice President SELL $9.03 63,202 $570,714 77,768 -44.8%
2019-03-02 03:55 2019-02-28 OSTRACH MICHAEL S Officer - Senior Vice President OPT+S $8.94 35,444 $316,763 86,772 0.0%
2018-12-08 03:23 2018-12-06 CANO FRANCIS Director SELL $10.47 2,000 $20,942 0 -100.0%
2018-06-09 02:37 2018-06-08 OSTRACH MICHAEL S Officer - Senior Vice President SELL $15.53 4,000 $62,100 76,554 -5.0%
2018-03-16 23:40 2018-03-15 Novack David F Officer - Senior Vice President SELL $16.30 16,109 $262,604 0 -100.0%
2018-03-16 02:45 2018-03-13 Novack David F Officer - Senior Vice President SELL $16.52 34,214 $565,106 16,109 -68.0%
2018-03-14 01:56 2018-03-09 Novack David F Officer - Senior Vice President SELL $17.97 2,121 $38,111 75,521 -2.7%
2018-02-24 04:02 2018-01-04 Johnson David Louis Officer - Vice President SELL $18.60 3,092 $57,511 2,636 -54.0%
2018-01-06 00:35 2018-01-04 Johnson David Louis Officer - Vice President SELL $18.60 3,092 $57,511 4,718 -39.6%
2017-12-16 00:47 2017-12-13 COFFMAN ROBERT Officer - Senior Vice President OPT+S $18.90 7,500 $141,750 6,308 0.0%
2017-01-27 03:11 2017-01-24 Janssen Robert Officer - Vice President BUY $4.04 6,000 $24,240 12,048 +99.2%
2016-06-30 13:51 2016-06-28 Janssen Robert Officer - Vice President BUY $13.68 1,452 $19,863 6,048 +31.6%
2016-05-23 16:10 2016-05-20 Gray Eddie Director, Officer - CEO and Director BUY $15.57 2,750 $42,819 5,250 +110.0%
2016-05-13 16:30 2016-05-12 Janssen Robert Officer - Vice President BUY $15.12 1,000 $15,120 1,000 +100.0%
2015-10-09 23:08 2015-10-08 Janssen Robert Officer - Vice President BUY $23.34 100 $2,334 100 +100.0%
2014-08-14 23:18 2014-08-14 Gray Eddie Director, Officer - CEO and Director BUY $1.49 25,000 $37,250 25,000 +100.0%
2013-10-30 23:30 2013-10-30 KISNER DANIEL L Director BUY $1.08 10,000 $10,750 15,000 +200.0%
2013-10-30 23:29 2013-10-30 ORONSKY ARNOLD L Director BUY $1.08 186,047 $200,001 375,055 +98.4%
2013-10-30 23:29 2013-10-30 Phillips Peggy V Director BUY $1.08 93,023 $100,000 138,023 +206.7%
2012-11-07 22:48 2012-11-06 COFFMAN ROBERT Officer - Chief Scientific Officer & VP OPT+S $4.31 8,000 $34,480 19,926 0.0%
2012-10-17 22:49 2012-10-16 KESSEL MARK Director SELL $4.73 6,000,000 $28,356,000 3,031,431 -66.4%
2012-10-09 23:01 2012-10-05 COFFMAN ROBERT Officer - Chief Scientific Officer & VP OPT+S $4.94 8,000 $39,525 37,992 0.0%
2012-09-14 23:19 2012-09-14 Lew Jennifer Officer - VP, Finance & PAO OPT+S $4.53 18,750 $84,938 2,332 0.0%
2012-09-14 23:13 2012-09-13 COFFMAN ROBERT Officer - Chief Scientific Officer & VP SELL $4.52 8,000 $36,160 3,111 -72.0%
2011-11-09 00:39 2011-11-08 ORONSKY ARNOLD L Director BUY $2.50 160,000 $400,000 189,008 +551.6%
2011-08-08 23:48 2011-08-05 CANO FRANCIS Director BUY $2.54 20,000 $50,706 20,000 +100.0%
2010-04-15 20:23 2010-04-13 DINA DINO Director, Officer - President, CEO and Director BUY $0.00 70,000 $0 70,000 +100.0%
2009-09-12 00:29 2009-09-10 BVF PARTNERS L P/IL 10% owner SELL $2.76 1,212,106 $3,350,988 4,278,851 -22.1%
SHOW ENTRIES
51-100 OF 154

How to Interpret $DVAX Trades

Not every insider transaction in DYNAVAX TECHNOLOGIES CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $DVAX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for DVAX

Insider activity data for DYNAVAX TECHNOLOGIES CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $DVAX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.